Fibroblast growth factor receptor 3 (FGFR3)
Showing 1 - 25 of >10,000
Urothelial Carcinoma Trial in Shanghai (AZD4547, Tislelizumab)
Recruiting
- Urothelial Carcinoma
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Mar 8, 2023
Metastatic Breast Cancer, FGFR 1 High Amplification, FGFR2 Amplification Trial in Worldwide (Futibatinib, Futibatinib plus
Recruiting
- Metastatic Breast Cancer
- +2 more
- Futibatinib
- Futibatinib plus Fulvestrant
-
Phoenix, Arizona
- +36 more
Jan 27, 2023
Bladder Transitional Cell Carcinoma, Bladder Cancer, Fibroblast Growth Factor Receptor Trial (Infigratinib)
Withdrawn
- Bladder Transitional Cell Carcinoma
- +2 more
- (no location specified)
Aug 8, 2022
Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma, Bladder Carcinoma Trial in Duarte, Iowa City, New York
Recruiting
- Advanced Solid Tumor
- +13 more
- [225Ac]-FPI-1966
- +2 more
-
Duarte, California
- +3 more
Oct 25, 2022
Locally Advanced Gastrointestinal Stromal Tumor, Locally Advanced Sarcoma, Metastatic Gastrointestinal Stromal Tumor Trial in
Recruiting
- Locally Advanced Gastrointestinal Stromal Tumor
- +7 more
- Biopsy
- +4 more
-
Duarte, California
- +17 more
Feb 2, 2023
Squamous-cell NSCLC Trial in Switzerland (Rogaratinib)
Active, not recruiting
- Squamous-cell Non-small Cell Lung Cancer
-
Baden, Switzerland
- +10 more
Jan 20, 2022
Advanced or Recurrent Solid Tumors, FGFR Gene Alterations Trial in Japan (E7090)
Recruiting
- Advanced or Recurrent Solid Tumors
- FGFR Gene Alterations
-
Aoba-ku, Sendai, Miyagi, Japan
- +4 more
May 9, 2022
Urinary Bladder Tumors, Receptors, Fibroblast Growth Factor Trial in Japan (Erdafitinib Intravesical Delivery System)
Not yet recruiting
- Urinary Bladder Neoplasms
- Receptors, Fibroblast Growth Factor
- Erdafitinib Intravesical Delivery System
-
Kanagawa, Japan
- +3 more
Jan 27, 2023
HR+/HER2- Advanced Breast Cancer, Targeted Therapy Trial in Beijing (Everolimus, Chidamide, Endocrine therapy)
Recruiting
- HR+/HER2- Advanced Breast Cancer
- Targeted Therapy
- Everolimus
- +3 more
-
Beijing, Beijing, ChinaNational Cancer Center/National Clinical Research Center for Can
Aug 1, 2023
Serum Insulin-like Growth Factor Binding Protein-3 asPotential
Not yet recruiting
- Colorectal Cancer
- evaluation of diagnostic importance of insulin like growth factor binding protein3 in patient with recently diagnosed as Colorectal cancer
- (no location specified)
May 6, 2023
Advanced Cancer, Metastatic Cancer Trial in Canada, United States (LY3076226)
Completed
- Advanced Cancer
- Metastatic Cancer
-
Philadelphia, Pennsylvania
- +3 more
Apr 9, 2020
Solid Tumours Trial in Worldwide (Debio1347 (CH5183284))
Terminated
- Solid Tumours
- Debio1347 (CH5183284)
-
Boston, Massachusetts
- +7 more
Sep 8, 2020
Epidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung Cancer Trial (HER3-DXd)
Available
- Epidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung Cancer
- (no location specified)
Oct 17, 2023
Advanced or Metastatic Solid Tumor Trial in Worldwide (Rogaratinib (BAY1163877), Copanlisib (BAY80-6946))
Completed
- Advanced or Metastatic Solid Tumor
- Rogaratinib (BAY1163877)
- Copanlisib (BAY80-6946)
-
Los Angeles, California
- +19 more
Jul 13, 2022
Breast Cancer Trial in Orange City (ARV-471 (PF-07850327), Palbociclib, Letrozole)
Recruiting
- Breast Cancer
- ARV-471 (PF-07850327)
- +2 more
-
Orange City, FloridaMid Florida Hematology and Oncology Center
Jun 8, 2023
Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation Trial in Canton (TAS6417)
Recruiting
- Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation
-
Canton, OhioGabrail Cancer and Research Center
Jul 25, 2023
Locally Advanced or Unresectable Metastatic Breast Cancer, Stage IV Breast Cancer Trial in Marietta, East Brunswick (Sacituzumab
Recruiting
- Locally Advanced or Unresectable Metastatic Breast Cancer
- Stage IV Breast Cancer
- Sacituzumab Govitecan-hziy
- +3 more
-
Marietta, Georgia
- +1 more
Apr 21, 2023
Breast Cancer Female Trial in Tomsk ([99mTc]Tc-G3-(G3S)3C)
Enrolling by invitation
- Breast Cancer Female
-
Tomsk, Russian FederationOlga
Jun 19, 2023
Recurrent/Advanced Gastric Cancer Trial in Seoul (Chemotherapy)
Not yet recruiting
- Recurrent/Advanced Gastric Cancer
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Aug 22, 2022
Pre-frail Elderly Trial in Jakarta (Cholecalciferol, Placebo)
Completed
- Pre-frail Elderly
- Cholecalciferol
- Placebo
-
Jakarta, DKI Jakarta, IndonesiaCipto Mangunkusumo General Hospital
Jan 25, 2023